1.A frequently missed entity in systemic lupus erythematosus (SLE): Intestinal pseudo-obstruction (IpsO)
Shirley LEE ; Rachel Joshua THUNDYIL
The Medical Journal of Malaysia 2017;72(6):374-375
Intestinal pseudo-obstruction (IpsO) is defined as presenceof clinical features of intestinal obstruction withoutidentifiable mechanical obstructive lesion. IpsO is anuncommon gastrointestinal manifestation of systemic lupuserythematosus (SLE) and is largely under-recognised. Thereare only over 30 published cases in English literature onSLE-related IpsO. Herein, we report two cases of SLE-relatedIpsO to illustrate the importance of early recognition toavoid unnecessary surgical intervention, as SLE-relatedIpsO responds well to systemic high dose corticosteroids.These two cases also demonstrate the apparent associationof IpsO with uretero-hydronephrosis, suggesting that thepossible mechanism could be smooth muscle dysmotility
2.Enforcement and analysis of the Objective Structured Teaching Evaluation
Hisayuki HAMADA ; Shirley LEE ; Abbas GHAVAM-RASSOUL ; Hisayoshi KONDO ; Hironori EZAKI ; Takashi OTANI ; Helen P BATTY
Medical Education 2010;41(5):325-335
In Japan, awareness has increased in recent years of the importance of evaluating clinical educators. In Europe and North America, the Objective Structured Teaching Evaluation (OSTE), which employs standardized students, multiple stations, video recording, and scoring by multiple observers, is used to evaluate clinical educators. We report on the implementation of an OSTE in Japan.1) Ten clinician-educator physicians participated in the OSTE, which comprised 5 stations and included standardized residents. The stations were video-recorded, and the educators were assessed by 7 different evaluators.2) The educators were evaluated with a checklist and a 5-point scale. We assessed the reliability and validity of the checklist and analyzed the background characteristics of the clinician educators.3) The factors most closely associated with high ratings on the checklist and the 5-point scale were: having a history of attendance at a seminar for clinician-educators, having greater than 5 years experience as an educator, and not being an internist. There was no interobserver variability among the evaluators.4) The generalizability of the checklist was 0.81, and its reliability index was 0.83. The correlation coefficient between the total scale score and the checklist score was 0.8. 5) Although biases by participants were identified, our project suggests that the OSTE could be used in Japan to objectively evaluate the teaching skills of clinician-educators. Further research on the OSTE in Japan is warranted.
4.Clinical comparison between neuroendocrine and endometrioid type carcinoma of the uterine corpus
Shirley MEI ; Jennifer GIBBS ; Katherine ECONOMOS ; Yi Chun LEE ; Margaux J KANIS
Journal of Gynecologic Oncology 2019;30(4):e58-
OBJECTIVE: To compare the clinicopathologic features and survival outcomes of neuroendocrine tumor of the uterine corpus (NET-U) to endometrioid type endometrial carcinoma (EC). METHODS: From 1993 to 2012, the Surveillance, Epidemiology and End Results cancer registry was queried for women diagnosed with EC or NET-U. Data regarding stage, grade, presence of extra-uterine disease, lymph node metastasis, receipt of adjuvant radiation, surgical intervention and overall survival (OS) was extracted. Chi-square tests, t-tests and Kaplan Meir curves were used for statistical analysis. RESULTS: A total of 98,363 patients were identified: 98,245 with EC and 118 with NET-U. The mean age at diagnosis for EC was 61.7 years and 64.8 years for NET-U (p=0.01). NET-U cases were more likely to be poorly differentiated (97.0% vs. 15.6%; p≤0.01) and have nodal metastasis (56.4% vs. 11.1%; p≤0.01) when compared to EC. Presence of extrapelvic disease at the time of diagnosis was observed more frequently in NET-U compared to EC, 49.1% vs. 4.8%, respectively (odds ratio=18; 95% confidence interval=13.1–27.2; p≤0.01). Significant improvement in OS was observed in NET-U patient who received radiation (OS: 7.7 vs. 3.3 years; p≤0.01) or underwent surgical management (5.6 vs. 0.9 years; p≤0.01). The OS for EC was 14.4 vs. 4.6 years for NET-U (p≤0.01). CONCLUSION: NET-U represents an aggressive form of uterine malignancy. When compared to EC, patients with NET-U present at more advanced stage, have more frequent extra-uterine disease and lower OS.
Carcinoma, Endometrioid
;
Diagnosis
;
Endometrial Neoplasms
;
Epidemiology
;
Female
;
Humans
;
Lymph Nodes
;
Neoplasm Metastasis
;
Neuroendocrine Tumors
;
Uterine Neoplasms
5.Genes Associated with Recurrence of Hepatocellular Carcinoma: Integrated Analysis by Gene Expression and Methylation Profiling.
Ju Dong YANG ; So Young SEOL ; Sun Hee LEEM ; Yong Hoon KIM ; Zhifu SUN ; Ju Seog LEE ; Snorri S THORGEIRSSON ; In Sun CHU ; Lewis R ROBERTS ; Koo Jeong KANG
Journal of Korean Medical Science 2011;26(11):1428-1438
Gene expression is suppressed by DNA methylation. The goal of this study was to identify genes whose CpG site methylation and mRNA expression are associated with recurrence after surgical resection for hepatocellular carcinoma (HCC). Sixty-two HCCs were examined by both whole genome DNA methylation and transcriptome analysis. The Cox model was used to select genes associated with recurrence. A validation was performed in an independent cohort of 66 HCC patients. Among fifty-nine common genes, increased CpG site methylation and decreased mRNA expression were associated with recurrence for 12 genes (Group A), whereas decreased CpG site methylation and increased mRNA expression were associated with recurrence for 25 genes (Group B). The remaining 22 genes were defined as Group C. Complement factor H (CFH) and myosin VIIA and Rab interacting protein (MYRIP) in Group A; proline/serine-rich coiled-coil 1 (PSRC1), meiotic recombination 11 homolog A (MRE11A), and myosin IE (MYO1E) in Group B; and autophagy-related protein LC3 A (MAP1LC3A), and NADH dehydrogenase 1 alpha subcomplex assembly factor 1 (NDUFAF1) in Group C were validated. In conclusion, potential tumor suppressor (CFH, MYRIP) and oncogenes (PSRC1, MRE11A, MYO1E) in HCC are reported. The regulation of individual genes by methylation in hepatocarcinogenesis needs to be validated.
Adult
;
Aged
;
Carcinoma, Hepatocellular/*genetics/pathology/surgery
;
CpG Islands
;
*DNA Methylation
;
Female
;
Gene Expression Profiling
;
Gene Expression Regulation, Neoplastic
;
Humans
;
Liver/pathology
;
Liver Neoplasms/*genetics/pathology/surgery
;
Male
;
Middle Aged
;
Neoplasm Recurrence, Local/*genetics
;
Oligonucleotide Array Sequence Analysis
;
Proportional Hazards Models
;
RNA, Messenger/biosynthesis
;
Transcriptome/genetics